Updated:
Nora Eccles Treadwell Charitable Trust
The Nora Eccles Treadwell Charitable Trust was established in 1962 with a dual mandate: to advance medical research in the Intermountain West and to steward a...
Nora Eccles Treadwell Charitable Trust
The Nora Eccles Treadwell Charitable Trust was established in 1962 with a dual mandate: to advance medical research in the Intermountain West and to steward a permanent endowment built from one of America's most consequential banking legacies. The trust's namesake was the daughter of Marriner S. Eccles, the former Federal Reserve chairman whose family built First Security Corporation into a regional banking powerhouse and whose policy legacy reshaped central banking. The trust's grantmaking arm channels significant funding to the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute, while its investment arm operates with the same quiet resolve that characterized the first-generation fortune. The trust has carved a distinctive path as a buyout-focused institutional allocator, committing to small and middle-market private equity funds while selectively pursuing direct co-investments in industrial technology, healthcare services, and life sciences companies. Its investment posture favors managers with operational expertise in regulated industries—a preference that reflects the Eccles family's own experience building durable businesses under exacting oversight. Geographically, the portfolio leans heavily into Western US private equity sponsors, with secondary exposure to national lower-middle-market funds. Confirmed commitments include positions in funds managed by Peterson Partners and Signal Peak Ventures, both Salt Lake City-based sponsors with deep ties to the region's healthcare and tech ecosystems (per the firms, 2020–2024). The trust operates through a compact governance structure headquartered in Salt Lake City. While its total endowment size remains undisclosed, its consistent participation in regional private equity funds alongside Utah's prominent family offices and the Church of Jesus Christ of Latter-day Saints' investment entity places it within a distinctive co-investor network. The trust also maintains a separate grantmaking entity, the Nora Eccles Treadwell Foundation, which historically focused on cardiovascular, diabetes, and arthritis research—though in recent years it has consolidated its philanthropic activity more directly under the trust's umbrella. In December 2023, the trust filed amendments to its investment policy governing its private co-investment program, signaling continued direct-deal activity (per public record, 2023). Structurally, the trust occupies a rare niche: a single-family-derived endowment that has outlived its founder by more than six decades while maintaining an independent, clinically precise allocation strategy. Unlike family offices that drift toward multi-generational consensus—and the diluted risk appetite that often follows—the Treadwell trust's board and investment committee have preserved a disciplined buyout bias without yielding to the donor-advised fund model that has absorbed many comparable foundations. That independence, backed by an endowment fortified through decades of private equity compounding, makes it one of the most durable, low-profile allocators operating between the Wasatch Range and the Pacific.
General information
Firm type
Foundation
Year founded
1962
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
Salt Lake City, UT, United States
Sector focus
Frequently asked questions
How does the trust's medical research grantmaking interact with its private equity investment strategy?
The trust maintains two functionally separate arms. The grantmaking side concentrates on cardiovascular, diabetes, and arthritis research, principally through sustained funding to the University of Utah's medical research infrastructure. The investment side pursues buyout fund commitments and direct co-investments across industrial tech, life sciences, and healthcare services. While there is some thematic overlap—investments in healthcare companies may operate adjacent to the research it funds—the trust enforces a structural separation between its philanthropic distribution and its private equity portfolio construction.
What is the trust's relationship to the broader Eccles family network of entities?
The trust is one of several investment and philanthropic vehicles tracing back to the Marriner Eccles lineage. Other entities include the Emma Eccles Jones Foundation, the George S. and Dolores Doré Eccles Foundation, and the Marriner S. Eccles Foundation. While these operate independently with distinct board compositions and grantmaking priorities, they are known to co-invest through overlapping fund relationships in the Salt Lake City private equity ecosystem. The Treadwell trust is notable for its narrower focus on private equity buyouts and its direct tie to medical research institutions.
Does the trust file a public Form 990-PF, and what does it disclose about its investment activity?
Yes, as a US-based private foundation, the trust files Form 990-PF annually. These filings disclose grantmaking recipients, compensation for key officers, and the fair market value of assets, though they do not provide line-item transparency into private equity fund positions. The trust's consistent asset growth patterns across filings suggest disciplined capital deployment into private equity vehicles with long lock-up periods, consistent with the buyout strategy reported in its investment policy statements.
Who runs investment decisions at the trust?
Public filings indicate the trust is governed by a board of trustees, which retains authority over the investment policy statement and overall asset allocation. Day-to-day manager selection and monitoring are delegated to an investment committee and, in certain periods, to external investment consultants. Exact trustee composition and investment committee members vary across filing years; the most recent publicly available 990-PF should be consulted for current officer and trustee names.
How can a private equity fund manager or direct deal sponsor approach the trust for investment consideration?
The trust does not maintain a public-facing investment portal or website, and does not publicly solicit investment proposals. In practice, access has historically been relationship-based, with regional placement agents and the Salt Lake City legal and accounting community serving as informal gateways. Fund managers seeking an introduction typically work through the trust's known fund relationships—Peterson Partners and Signal Peak Ventures among them—or through legal counsel with established ties to the Eccles family's network of advisors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: